203 related articles for article (PubMed ID: 18306362)
1. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.
Aliyu ZY; Gordeuk V; Sachdev V; Babadoko A; Mamman AI; Akpanpe P; Attah E; Suleiman Y; Aliyu N; Yusuf J; Mendelsohn L; Kato GJ; Gladwin MT
Am J Hematol; 2008 Jun; 83(6):485-90. PubMed ID: 18306362
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.
Gladwin MT; Sachdev V; Jison ML; Shizukuda Y; Plehn JF; Minter K; Brown B; Coles WA; Nichols JS; Ernst I; Hunter LA; Blackwelder WC; Schechter AN; Rodgers GP; Castro O; Ognibene FP
N Engl J Med; 2004 Feb; 350(9):886-95. PubMed ID: 14985486
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
[TBL] [Abstract][Full Text] [Related]
4. Lower than expected elevated tricuspid regurgitant jet velocity in adults with sickle cell disease in Nigeria.
Musa BM; Odoh CN; Galadanci NA; Saidu H; Aliyu MH
Int Health; 2018 Sep; 10(5):356-362. PubMed ID: 29438485
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension in children and adolescents with sickle cell disease.
Onyekwere OC; Campbell A; Teshome M; Onyeagoro S; Sylvan C; Akintilo A; Hutchinson S; Ensing G; Gaskin P; Kato G; Rana S; Kwagyan J; Gordeuk V; Williams J; Castro O
Pediatr Cardiol; 2008 Mar; 29(2):309-12. PubMed ID: 17680298
[TBL] [Abstract][Full Text] [Related]
6. Serum apelin as a novel non-invasive marker for subclinical cardiopulmonary complications in children and adolescents with sickle cell disease.
Elbarbary NS; Ismail EA; Roushdy A; Fahmy E
Blood Cells Mol Dis; 2016 Mar; 57():1-7. PubMed ID: 26852648
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity.
El-Shanshory M; Badraia I; Donia A; Abd El-Hameed F; Mabrouk M
Eur J Haematol; 2013 Jul; 91(1):55-61. PubMed ID: 23551575
[TBL] [Abstract][Full Text] [Related]
8. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
[TBL] [Abstract][Full Text] [Related]
9. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension.
Liem RI; Young LT; Thompson AA
Haematologica; 2007 Nov; 92(11):1549-52. PubMed ID: 18024403
[TBL] [Abstract][Full Text] [Related]
10. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
[TBL] [Abstract][Full Text] [Related]
11. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation.
Minniti CP; Sable C; Campbell A; Rana S; Ensing G; Dham N; Onyekwere O; Nouraie M; Kato GJ; Gladwin MT; Castro OL; Gordeuk VR
Haematologica; 2009 Mar; 94(3):340-7. PubMed ID: 19211639
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive estimation of pulmonary artery pressures in patients with sickle cell anaemia in Ibadan, Nigeria: an echocardiographic study.
Enakpene EO; Adebiyi AA; Ogah OS; Olaniyi JA; Aje A; Adeoye MA; Falase AO
Acta Cardiol; 2014 Oct; 69(5):505-11. PubMed ID: 25638838
[TBL] [Abstract][Full Text] [Related]
13. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease.
Liem RI; Nevin MA; Prestridge A; Young LT; Thompson AA
Pediatr Pulmonol; 2009 Mar; 44(3):281-9. PubMed ID: 19205056
[TBL] [Abstract][Full Text] [Related]
14. The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis.
Musa BM; Galadanci NA; Coker M; Bussell S; Aliyu MH
Ann Hematol; 2016 Oct; 95(11):1757-64. PubMed ID: 27181705
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in Nigerian adults with sickle cell anemia.
Amadi VN; Balogun MO; Akinola NO; Adebayo RA; Akintomide AO
Vasc Health Risk Manag; 2017; 13():153-160. PubMed ID: 28507438
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.
Machado RF; Anthi A; Steinberg MH; Bonds D; Sachdev V; Kato GJ; Taveira-DaSilva AM; Ballas SK; Blackwelder W; Xu X; Hunter L; Barton B; Waclawiw M; Castro O; Gladwin MT;
JAMA; 2006 Jul; 296(3):310-8. PubMed ID: 16849664
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hypertension in sickle cell disease: diagnosis and management.
Ataga KI; Klings ES
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):425-31. PubMed ID: 25696889
[TBL] [Abstract][Full Text] [Related]
18. Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance.
Chaudry RA; Cikes M; Karu T; Hutchinson C; Ball S; Sutherland G; Rosenthal M; Bush A; Crowley S
Arch Dis Child; 2011 Feb; 96(2):131-6. PubMed ID: 21030373
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.
Niss O; Quinn CT; Lane A; Daily J; Khoury PR; Bakeer N; Kimball TR; Towbin JA; Malik P; Taylor MD
JACC Cardiovasc Imaging; 2016 Mar; 9(3):243-52. PubMed ID: 26897687
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension of sickle cell disease: more than just another lung disease.
Klings ES
Am J Hematol; 2008 Jan; 83(1):4-5. PubMed ID: 17924550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
